Figure 2From: Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration Pharmacodynamic profile of PXS-4728A 24Â hours after dosing. Measurement of total VAP-1/SSAO activity (%) compared to untreated control; (A) single time point with escalating doses in the (A) adipose tissue of BALB/c mice (B) adipose tissue of Wistar rats (C) lung of Wistar rats.Back to article page